Substance P downregulates expression of the high affinity IgE receptor (FcεRI) by human mast cells

Journal of Neuroimmunology

Volumn 220, Issue 1-2, 2010, Pages 17-24

  McCary, Christine ^b   Tancowny, Brian P ^b   Catalli, Adriana ^a   Grammer, Leslie C ^b   Harris, Kathleen E ^b   Schleimer, Robert P ^b   Kulka, Marianna ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fc receptor; IgE; Mast cells; Stress; Substance P

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E RECEPTOR; MESSENGER RNA; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ARTICLE; CELL ACTIVATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; NEURITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; STRESS;

ALLERGENS; CELL DEGRANULATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENCEPHALITIS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; RECEPTORS, IGE; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SUBSTANCE P;

EID: 77649182704     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.12.006     Document Type: Article

References (33)

1. Alshurafa H.N., Stenton G.R., Wallace J.L., Hollenberg M.D., Befus A.D., and Vliagoftis H. A protease activated receptor-2 (PAR-2) activating peptide, tc- LI GRL O- NH2, induces protease release from mast cells: role in TNF degradation. BMC Pharmacol. 4 (2004) 12
2. Bienenstock J., MacQueen G., Sestini P., Marshall J.S., Stead R.H., and Perdue M.H. Mast cell/nerve interactions in vitro and in vivo. Am. Rev. Respir. Dis. 143 (1991) S55-S58
3. Bulut K., Felderbauer P., Deters S., Hoeck K., Schmidt-Choudhury A., Schmidt W.E., and Hoffmann P. Sensory neuropeptides and epithelial cell restitution: the relevance of SP-and CGRP-stimul mast cells. Int. J. Colorectal. Dis. 23 (2008) 535-541
4. Ercan F., Akici A., Ersoy Y., Hurdag C., and Erin N. Inhibition of substance P activity prevents stress-induced bladder damage. Regul. Pept. 133 (2006) 82-89
5. Fukuoka Y., and Schwartz L.B. Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Biochemistry 43 (2004) 10757-10764
6. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23 (2005) 749-786
7. Groneberg D.A., Quarcoo D., Frossard N., and Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy 59 (2004) 1139-1152
8. He S.H., and Zheng J. Stimulation of mucin secretion from human bronchial epithelial cells by mast cell chymase. Acta Pharmacol. Sin. 25 (2004) 827-832
9. Kang H.S., Trzaska K.A., Corcoran K., Chang V.T., and Rameshwar P. Neurokinin receptors: relevance to the emerging immune system. Arch. Immunol Ther. Exp. Warsz 52 (2004) 338-347
10. Kawahira K., Sumiyoshi M., Sakanaka M., and Kimura Y. Effects of ginsenoside Rb1 at low doses on histamine, substance P, and monocyte chemoattractant protein 1 in the burn wound areas during the process of acute burn wound repair. J. Ethnopharmacol. 117 (2008) 278-284
11. Kirshenbaum A.S., Goff J.P., Semere T., Foster B., Scott L.M., and Metcalfe D.D. Demonstration that human mast cells arise from a progenit or cell populati on that is CD34 (+), c-kit (+), and expresses aminopeptidase N CD13. Blood 94 (1999) 2333-2342
12. Kirshenbaum A.S., Akin C., Wu Y., Rottem M., Goff J.P., Beaven M.A., Rao V.K., and Metcalfe D.D. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcgammaRI. Leukoc. Res. 27 (2003) 677-682
13. Kuehn H.S., and Gilfillan A.M. G protein-coupled receptors and the modification of FcεRI-mediated mast cell activation. Immunol. Lett. 113 (2007) 59-69
14. Kulka M., Sheen C.H., Tancowny B.P., Grammer L.C., and Schleimer R.P. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology (2007)
15. Kulka M., Sheen C.H., Tancowny B.P., Grammer L.C., and Schleimer R.P. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123 (2008) 398-410
16. Lambrecht B.N. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir. Res. 2 (2001) 133-138
17. Lambrecht B.N., Germonpre P.R., Everaert E.G., Carro-Muino I., De Veerman M., de Felipe C., Hunt S.P., Thielemans K., Joos G.F., and Pauwels R.A. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur. J Immunol. 29 (1999) 3815-3825
18. Langer I., and Robberecht P. Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors. Biochem. Soc. Trans. 35 (2007) 724-728
19. Langer I., Langlet C., and Robberecht P. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor. J. Mol. Endocrinol. 34 (2005) 405-414
20. Montero Mora P., Gonzalez Perez Mdel C., Almeida Arvizu V., and Matta Campos J.J. [Autoimmune urticaria. Treatment with methotrexate]. Rev. Alerg. Mex. 51 (2004) 167-172
21. Mousli M., Bronner C., Bockaert J., Rouot B., and Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha- subunit C-terminus of G protein. Immunol. Lett. 25 (1990) 355-357
22. Mousli M., Bronner C., Landry Y., Bockaert J., and Rouot B. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett. 259 (1990) 260-262
23. Muramatsu M., Katada J., Hattori M., Hayashi I., and Majima M. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur. J. Pharmacol. 402 (2000) 181-191
24. Nieber K., Baumgarten C.R., Rathsack R., Furkert J., Oehme P., and Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90 (1992) 646-652
25. Nieber K., Baumgarten C., Rathsack R., Furkert J., Laake E., Muller S., and Kunkel G. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin. Exp. Allergy 23 (1993) 69-71
26. O'Connor T.M., O'Connell J., O' Brien D.I., Goode T., Bredin C.P., and Shanahan F. The role of substance P in inflammatory disease. J. Cell. Physiol. 201 (2004) 167-180
27. Patterson R., Harris K.E., Grammer L.C., Greenberger P.A., Ditto A.M., and Shaughnessy M.A. Potential effect of the administration of substance P and allergen therapy on immunoglobulin E-mediated allergic reactions in human subjects. J. Lab. Clin. Med. 133 (1999) 189-199
28. Siebenhaar F., Magerl M., Peters E.M., Hendrix S., Metz M., and Maurer M. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J. Allergy Clin. Immunol. 121 (2008) 955-961
29. Tatemoto K., Nozaki Y., Tsuda R., Konno S., Tomura K., Furuno M., Ogasawara H., Edamura K., Takagi H., Iwamura H., Noguchi M., and Naito T. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem. Biophys. Res. Commun. 349 (2006) 1322-1328
30. Tuluc F., Lai J.P., Kilpatrick L.E., Evans D.L., and Douglas S.D. Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol. 30 (2009) 271-276
31. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034
32. Weinstock J.V., Blum A., Walder J., and Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J. Immunol. 141 (1988) 961-966
33. Yamaguchi M., Sayama K., Yano K., Lantz C.S., Noben-Trauth N., Ra C., Costa J.J., and Galli S.J. IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of I L-4 and IgE on human mast cell Fcepsilon receptor I expression and mediator release. J. Immunol. (Baltimore, Md.: 1950) 162 (1999) 5455-5465